Director awarded 870 restricted stock shares
Rigaud Olivier, a director of issuer BCPC, reported an award of restricted common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rigaud Olivier, a director of issuer BCPC, reported an award of restricted common stock. On February 11, 2026, he acquired 870 shares at $0 per share as a grant, increasing his directly held common stock to 2,390 shares after the transaction.
The footnote explains that this restricted stock will vest in the reporting person one year after the grant date, and remains subject to transfer restrictions under a Restricted Stock Grant Agreement between the issuer and the director.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 870 | $0.00 | $0.00 |
Footnotes (1)
- F1. Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BCPC director Rigaud Olivier report on this Form 4?
Is the February 11, 2026 BCPC stock grant to director Rigaud Olivier an open-market purchase?
What does transaction code A mean in Rigaud Olivier’s BCPC Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.